Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5 (5159062) MAJOR CONCEPT MAP (757)
Name
Value
EXPRESSION
Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5
